MedTrace Logo

Assessment of Iron Deposition in Major Organs of Hemodialysis Patients

NCT01169961 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2010-07-26

No results posted yet for this study

Summary

The purpose of the present study is to evaluate in hemodialysis patients, who have elevated serum ferritin ( \>2000ng/ml) and transferrin saturation (TSAT) \>30%, iron deposition in the heart, pancreas, liver and spleen using the T2\* MRI technique.

In addition, we will also measure the free iron forms in the plasma and LPI, LCI in red blood cells, platelets and PMN, in addition to serum hepcidin, TSAT, serum ferritin, CRP and oxidative stress parameters (ROS,GSH, and malonyldialdehyde (MDA).

Conditions

  • Iron Overload

Sponsors & Collaborators

  • Wolfson Medical Center

    lead OTHER_GOV

Principal Investigators

  • GHOTI HOSSAM · HEMATOLOGY DEPARTMENT ON WOLFSSON MEDICAL CENTER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01169961 on ClinicalTrials.gov